Chemically ‘stapled’ peptides used to target difficult-to-treat cancers (VIDEO)

University of Bath

Caption

Professor Jody Mason, from the University of Bath and CEO of Revolver Therapeutics, explains the new technology.

Credit

University of Bath

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.